Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
3197 | 1963 | 29.7 | 65% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | GOUT | Author keyword | 522 | 51% | 37% | 724 |
2 | TOPHI | Author keyword | 105 | 88% | 3% | 50 |
3 | FEBUXOSTAT | Author keyword | 94 | 65% | 5% | 91 |
4 | TOPHUS | Author keyword | 80 | 80% | 2% | 49 |
5 | URATE LOWERING THERAPY | Author keyword | 50 | 86% | 1% | 25 |
6 | TOPHACEOUS GOUT | Author keyword | 35 | 74% | 1% | 26 |
7 | PEGLOTICASE | Author keyword | 35 | 86% | 1% | 18 |
8 | HYPERURICEMIA | Author keyword | 34 | 19% | 8% | 159 |
9 | GOUTY ARTHRITIS | Author keyword | 25 | 45% | 2% | 42 |
10 | ALLOPURINOL | Author keyword | 22 | 15% | 7% | 141 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | GOUT | 522 | 51% | 37% | 724 | Search GOUT | Search GOUT |
2 | TOPHI | 105 | 88% | 3% | 50 | Search TOPHI | Search TOPHI |
3 | FEBUXOSTAT | 94 | 65% | 5% | 91 | Search FEBUXOSTAT | Search FEBUXOSTAT |
4 | TOPHUS | 80 | 80% | 2% | 49 | Search TOPHUS | Search TOPHUS |
5 | URATE LOWERING THERAPY | 50 | 86% | 1% | 25 | Search URATE+LOWERING+THERAPY | Search URATE+LOWERING+THERAPY |
6 | TOPHACEOUS GOUT | 35 | 74% | 1% | 26 | Search TOPHACEOUS+GOUT | Search TOPHACEOUS+GOUT |
7 | PEGLOTICASE | 35 | 86% | 1% | 18 | Search PEGLOTICASE | Search PEGLOTICASE |
8 | HYPERURICEMIA | 34 | 19% | 8% | 159 | Search HYPERURICEMIA | Search HYPERURICEMIA |
9 | GOUTY ARTHRITIS | 25 | 45% | 2% | 42 | Search GOUTY+ARTHRITIS | Search GOUTY+ARTHRITIS |
10 | ALLOPURINOL | 22 | 15% | 7% | 141 | Search ALLOPURINOL | Search ALLOPURINOL |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | TOPHACEOUS GOUT | 187 | 74% | 7% | 140 |
2 | HYPERURICEMIA | 139 | 28% | 22% | 428 |
3 | URATE LOWERING THERAPY | 98 | 100% | 1% | 29 |
4 | TOPHI | 96 | 86% | 2% | 49 |
5 | SERUM URATE | 70 | 54% | 5% | 91 |
6 | PURINE RICH FOODS | 69 | 73% | 3% | 52 |
7 | INCIDENT GOUT | 64 | 79% | 2% | 41 |
8 | XANTHINE OXIDASE XANTHINE DEHYDROGENASE | 61 | 95% | 1% | 20 |
9 | ANTIHYPERURICEMIC THERAPY | 60 | 100% | 1% | 20 |
10 | URATE LOWERING DRUGS | 58 | 92% | 1% | 23 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Multinational evidence-based recommendations for the diagnosis and management of gout: integrating systematic literature review and expert opinion of a broad panel of rheumatologists in the 3e initiative | 2014 | 21 | 88 | 75% |
EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR standing committee for international clinical studies including therapeutics (ESCISIT) | 2006 | 427 | 71 | 63% |
Evolution of management of gout: a comparison of recent guidelines | 2015 | 2 | 31 | 97% |
Optimizing current treatment of gout | 2014 | 12 | 113 | 76% |
A systematic review of ultrasonography in gout and asymptomatic hyperuricaemia | 2013 | 23 | 34 | 76% |
A Review of Uric Acid, Crystal Deposition Disease, and Gout | 2015 | 2 | 45 | 73% |
Update on gout: new therapeutic strategies and options | 2010 | 92 | 46 | 70% |
Drug therapy - The management of gout | 1996 | 247 | 49 | 51% |
Artifacts in Dual-Energy CT Gout Protocol: A Review of 50 Suspected Cases With an Artifact Identification Guide | 2014 | 5 | 8 | 88% |
New Therapies for Gout | 2013 | 15 | 39 | 69% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CLIN GOUT | 4 | 75% | 0.2% | 3 |
2 | INSERM 1132 | 4 | 75% | 0.2% | 3 |
3 | BIOMED ANALYT SCI | 3 | 57% | 0.2% | 4 |
4 | AUCKLAND RHEUMATOL IMAGING GRP | 3 | 100% | 0.2% | 3 |
5 | KREISKLIN BALINGEN | 3 | 100% | 0.2% | 3 |
6 | SUMITOMO HOSP | 3 | 45% | 0.3% | 5 |
7 | BONE JOINT GRP | 3 | 12% | 1.2% | 23 |
8 | ARAMIS PROGRAM | 2 | 67% | 0.1% | 2 |
9 | DE GROOTE MED | 2 | 67% | 0.1% | 2 |
10 | MUSCULOSKELETAL ULTRASONOG | 2 | 67% | 0.1% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000288243 | MONOSODIUM URATE MONOHYDRATE//MONOSODIUM URATE CRYSTALS//MSU CRYSTALS |
2 | 0.0000245910 | URIC ACID//SERUM URIC ACID//HYPERURICEMIA |
3 | 0.0000146434 | OXYPURINOL//OXIPURINOL//CAS 315 30 0 |
4 | 0.0000138625 | XANTHINE OXIDASE INHIBITORS//THIENOTRIAZOLOPYRIMIDINE//A1 ADENOSINE RECEPTOR LIGANDS |
5 | 0.0000116547 | CHONDROCALCINOSIS//PSEUDOGOUT//CALCIUM PYROPHOSPHATE DIHYDRATE |
6 | 0.0000063943 | COLCHICUM AUTUMNALE//COLCHICINOIDS//COLCHICINE |
7 | 0.0000049086 | TUMOR LYSIS SYNDROME//RASBURICASE//ACUTE TUMOR LYSIS SYNDROME |
8 | 0.0000048525 | BENZARONE//BENZBROMARONE//EQUATORIAL CONFORMATION |
9 | 0.0000039310 | DRUG INDUCED HYPERSENSITIVITY SYNDROME//HLA B5701//HYPERSENSITIVITY SYNDROME |
10 | 0.0000031983 | SYNOVITIS//CLIN REUMATOL//ENTHESITIS |